Editorial Foreword - Milnacipran: recent findings in depression
Stuart Montgomery1, Mike Briley2 1Imperial College School of Medicine, London, England, UK; 2NeuroBiz Consulting and Communication, Castres, FranceMilnacipran: recent findings in depressionMilnacipran is a serotonin and norepinephrine reuptake inhibitor (SNRI) which was first approved for the treatm...
Guardado en:
Autores principales: | Stuart Montgomery, Mike Briley |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b865ead338664fdc9c611ed1c9f0f16d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Milnacipran: recent findings in depression
por: Guest editors: Stuart Montgomery (London, et al.
Publicado: (2010) -
Treatment of patients with comorbid depression and diabetes with metformin and milnacipran
por: Peter Hofmann
Publicado: (2010) -
Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder
por: Alla Avedisova, et al.
Publicado: (2009) -
Noradrenergic symptom cluster in depression
por: Montgomery S, et al.
Publicado: (2011) -
Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression
por: Kamijima K, et al.
Publicado: (2013)